40.40 - 41.05
29.80 - 47.18
2.12M / 3.68M (Avg.)
18.02 | 2.27
View analysts' price targets and recommendations, and compare them with competitors.
$52.00
Analysts expect the stock price to increase by 27.11%.
Buy
Positive consensus among analysts.
Analyze analyst forecasts for the company and compare them with competitors.
9.39B
The estimated revenue has increased from the previous period.
1.88B
The estimated EBITDA has increased from the previous period.
4.50
The estimated EPS has decreased from the previous period.
1.21B
The estimated net income has decreased from the previous period.
-28.33M
The estimated EBIT has decreased from the previous period.
1.63B
The estimated SG&A expenses have increased from the previous period.
Analyze DCF forecasts for the company and compare them with competitors.
12.32B
Revenue has increased from the previous period.
15.56%
Revenue growth rate has increased from the previous period.
2.46B
EBITDA has decreased from the previous period.
20.00%
EBITDA margin has decreased from the previous period.
-37.17M
EBIT has decreased from the previous period.
-0.30%
EBIT margin has decreased from the previous period.
2.50B
Depreciation has increased from the previous period.
130.83M
Total cash has increased from the previous period.
1.06%
Cash percentage has increased from the previous period.
1.75B
Receivables have increased from the previous period.
14.23%
Receivables percentage has increased from the previous period.
14.44M
Inventories have increased from the previous period.
0.12%
Inventory percentage has increased from the previous period.
566.31M
Accounts payable has decreased from the previous period.
4.60%
Payables percentage has decreased from the previous period.
-3.09B
Capital expenditure has increased from the previous period.
-25.11%
CapEx percentage has decreased from the previous period.
12.06%
WACC has increased from the previous period.
16.87%
Cost of equity is unchanged from the previous period.
5.31%
Cost of debt is unchanged from the previous period.
2.64
Beta is unchanged from the previous period.
263.90M
Diluted shares outstanding is unchanged from the previous period.
6.68B
Total debt is unchanged from the previous period.
10.03B
Total equity is unchanged from the previous period.
16.71B
Total capital is unchanged from the previous period.
39.98%
Debt weighting is unchanged from the previous period.
60.02%
Equity weighting is unchanged from the previous period.
-34.00M
EBIAT has decreased from the previous period.
-1.07B
UFCF has decreased from the previous period.
0.50%
Long-term growth rate is unchanged from the previous period.
-12.22B
Terminal value is unchanged from the previous period.
-10.90B
Enterprise value has increased from the previous period.
6.68B
Net debt is unchanged from the previous period.
-17.58B
Equity value has increased from the previous period.
-66.63
Equity value per share has increased from the previous period.
